Podcast Atlas

Bobbie: Laura Modi. How a Baby Formula Startup Took Market Share From Two Industry Giants

source Episode summary Updated 2026-08-17 Tags: Podcast, Cpg, Infant-Formula, Regulated-Consumer-Products, Founder-Story

Summary

This How I Built This episode follows Laura Modi from Google and Airbnb into founding Bobbie after her own painful experience with breastfeeding pressure and buying infant formula. The episode’s main wiki contribution is a regulated CPG case where Formula Feeding Stigma, Infant Formula Regulatory Moat, Regulated CPG Messaging, Formula Supply Chain Resilience, and WIC Formula Contracting shape both the product and the company strategy. It also extends the wiki’s Consumer Brand Moat branch by showing that in a parent-and-baby category, trust depends on emotional permission, FDA compliance, manufacturing control, subscription reliability, and policy engagement.

Key Claims

  • The U.S. infant formula market is presented as a roughly $6 billion category dominated by Enfamil and Similac, with little perceived change for decades.
  • Laura Modi’s founder insight came from a 2016 feeding experience: breastfeeding difficulty, infection, a late-night formula purchase, and shame around asking for access to locked formula.
  • The episode frames Bobbie’s position as pro-choice for feeding, not anti-breastfeeding: Modi calls breast milk irreplaceable while arguing that many families need high-quality alternatives.
  • Modi saw demand signals in U.S. parents informally importing European formula, and she built Bobbie around a European-style nutritional frame made for the U.S. market.
  • The first product path was risky: Bobbie launched a German-made pilot as a “companion formula” to 93 San Francisco families, but the FDA treated it as infant formula and issued a national recall.
  • The recall became a trust and compliance turning point because Bobbie apologized, stopped fighting the regulator publicly, and later won manufacturing support from Perrigo.
  • FDA approval and manufacturing conversion took about 18 months plus another six-month wait for a green-light letter, forcing Bobbie to build community and content before revenue.
  • Sarah Hardy joined as co-founder and COO because Modi wanted a culture-first partner from Airbnb rather than only a scientist as co-founder.
  • Bobbie launched in January 2021 as a direct-to-consumer formula and quickly exceeded first-year expectations, reaching $16 million in sales against an initial hope of about $4 million.
  • Demand quickly exposed a forecasting and inventory problem: formula lead times of five to six months forced Bobbie to protect existing subscribers and turn off growth.
  • The 2022 formula shortage, tied in the episode to an Abbott Nutrition Similac recall and facility shutdown, made Bobbie’s subscriber-protection choice strategically central.
  • Bobbie later bought Nature’s One and its Ohio facility, kept the Baby’s Only toddler-formula brand, and pursued owned manufacturing after realizing dependence on one contract manufacturer was a survival risk.
  • The episode says Bobbie was doing hundreds of millions of dollars in sales in 2026, had just under 4% U.S. market share, and wanted to reach about 10% rather than become the largest incumbent.
  • WIC is presented as a structural limit: state contracts can restrict eligible families to one winning formula brand, and Bobbie is not yet large enough to serve that program.
  • Bobbie for Change extends the business into advocacy, including a mentioned bill for insurance coverage of infant formula for women who have had breast cancer.

Key Quotes

“liquid gold” - Modi’s phrase for breast milk while explaining why formula should not be framed as an attack on breastfeeding.

“companion formula” - the label Bobbie used for its German-made pilot before the FDA recall.

“hustle with heart” - Modi’s phrase for the mix of work, luck, and mission behind Bobbie’s progress.

Connections

Contradictions

  • No direct contradiction found. The episode complements existing regulated-product and CPG pages by showing a stricter category than supplements or ordinary snacks: infant formula must combine parental trust, FDA permission, compliant claims, reliable manufacturing, inventory discipline, and government-program access before customer love can safely scale.